- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01129765
Home Usability of a Nasal Lavage System in Children
Study Overview
Status
Intervention / Treatment
Detailed Description
Nasal congestion is an important complication of viral upper respiratory infections in young children. It can lead to poor eating, sleeping and breathing. Recently, the FDA recommended against using over-the-counter cold remedies in young children because of inefficacy and occasional dangerous side effects. A commonly recommended non-drug solution for nasal congestion is nasal suctioning. This can be effective but currently available methods have been found to be awkward, uncomfortable and ineffective.
The studied device has potential for making nasal suctioning easy to perform in the home setting, especially in young children. It is already FDA cleared for professional use and this study was developed to demonstrate that it is appropriate for the home as well. This would be significant as it would allow parents a strategy of clearing their child's nose without drugs.
The device is automatic and handheld that can irrigate and/or aspirate the nasal cavity with hospital-grade suction. The handle houses a pump that can achieve air flows known to be effective for infant nasal suctioning in the hospital. A disposable wash-head is placed on top. It has an irrigation chamber with 0.9% saline and another chamber for collecting the aspirated nasal contents. The unit operates from a single bi-functional button.
Several key safety features have been built in such as: a tip that is shaped to maximize the seal but prevent intrusion into the nose; an irrigation function that delivers an optimal volume but prevents flooding the nasal cavity; and a pump that can deliver suction known to be effective in the hospital but whose safety valve does not allow it to rise above dangerous levels.
Participants were parents of children who have nasal congestion for whom nasal suctioning is traditionally recommended. They were asked to review the instruction manual of the device, and then use it on their children.
The primary outcome was proper use of device that was precisely defined. Additionally, subjective efficacy of mucus removal, evidence of adverse events and understanding of the device's user manual were also measured.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Virginia
-
Vienna, Virginia, United States, 22180
- Advanced Pediatrics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Parents of children less than 6 years of age who were suffering from nasal congestion for which nasal suctioning and salt water irrigation/drops are prescribed.
Exclusion Criteria:
- Parents of children in marked respiratory distress or who maxillofacial malformations not conducive to nasal suctioning.
- Additionally, parents of children with recurrent nose bleeds, bleeding disorders or irritated peri-nasal skin were excluded.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Parents of congested children
Parents of children less than six years of age with nasal congestion for which nasal suctioning and salt water irrigation is traditionally recommended.
|
After reading the device's user manual, parents were asked to use it on their congested children to their satisfaction.
During this time, a clinical observer recorded predetermined steps that needed to be performed for success as well as presence of any adverse events.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Properly Used the Nasal Irrigator/Aspirator Device
Time Frame: Day one, immediately
|
'Proper use' is defined as successfully completing all of the following five steps:
|
Day one, immediately
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Experienced Ease of Use With the Device
Time Frame: Day one, immediately
|
After using the device, the caregiver answered this question on a five point Likert-like scale with increasing favorability with increasing number. An answer of 3 or greater is considered an affirmative answer. Such responses reported along with the exact 95% confidence intervals. The question and scale are as follows: How easy was the device to use? 1 difficult, 2 somewhat hard, 3 fairly easy, 4 easy, 5 very easy |
Day one, immediately
|
|
Number of Participants Who Found the Device to be Effective
Time Frame: Day one, immediately
|
After using the device, the caregiver answered this question on a five point Likert-like scale with increasing favorability with increasing number. The proportion answering 3 or greater is reported along with the exact 95% confidence intervals. The question and scale are as follows: How well did the device remove nasal secretions? 1 difficult, 2 somewhat hard, 3 fairly easy, 4 easy, 5 very easy |
Day one, immediately
|
|
Number of Participants Who Identified the Device's User Manual as Easy to Understand
Time Frame: Day one, immediately
|
After using the device, the caregiver answered this question on a five point Likert-like scale with increasing favorability with increasing number. The proportion answering 3 or greater is reported along with the exact 95% confidence intervals. The question and scale are as follows: How easy was the manual to understand? 1 difficult, 2 somewhat hard, 3 fairly easy, 4 easy, 5 very easy |
Day one, immediately
|
|
Number of Patients Who Were Observed to Have an Adverse Event
Time Frame: Day one, immediately
|
While using the device, the patients were observed by the research coordinator for any of the following adverse events to occur:
|
Day one, immediately
|
|
Number of Patients Experiencing a Physical Injury During Use
Time Frame: Day one, immediately
|
After the procedure, the patient was directly examined for any of the following:
|
Day one, immediately
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Richard Schwartz, MD, Advanced Pediatrics
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AM-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sinusitis
-
Loma Linda UniversityWithdrawnChronic Sinus Disease | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Maxillary Bilateral | Chronic Sinusitis - Frontoethmoidal
-
LifeBridge HealthUnknownChronic Sinusitis | Nasal Polyps | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Frontoethmoidal | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinusitis - Ethmoidal Anterior | Nasal Polyp - PosteriorUnited States
-
Assiut UniversityNot yet recruitingDeviated Nasal Septum Effect on Maxillary Sinus Volumes and Development of Maxillary Sinusitis by CTDeviated Nasal Septum and Maxillary Sinusitis
-
Collin County Ear Nose & ThroatIntersect ENTCompletedChronic Sinusitis, EthmoidalUnited States
-
Tampere University HospitalRecruitingMaxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis RecurrentFinland
-
STS MedicalNot yet recruitingChronic Sinusitis, Ethmoidal
-
Ayu, Inc.CompletedSinusitis | Rhinosinusitis | Chronic Rhino-sinusitisMalaysia
-
Deraya UniversityCompleted
-
St. Louis UniversityTerminatedStent | Sinusitis, FrontalUnited States
-
Shanghai Yidian Pharmaceutical Technology Development...RecruitingChronic Sinusitis Without Nasal PolypsChina
Clinical Trials on Use of an automatic nasal irrigator/aspirator
-
East Tennessee Children's HospitalNot yet recruitingCleft Lip | Nasal Surgical Procedures
-
University Hospital, MontpellierRecruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingPheochromocytoma | ParagangliomaFrance
-
Medtronic Cardiac Rhythm and Heart FailureMedtronicCompleted
-
St. James's Hospital, IrelandUniversity of Dublin, Trinity CollegeRecruitingProteinuria | Chronic Kidney Disease | Tuberous Sclerosis Complex | Nephrotic Syndrome | Cancer Survivors | Blood Pressure Control | Congenital Anomalies of the Kidneys and Urinary Tract | Sickle-Cell NephropathyIreland
-
University Hospital, MontpellierNot yet recruiting
-
VA Office of Research and DevelopmentCompleted
-
Aalborg UniversityDagrofa Logistics A/SCompletedWork-related Musculoskeletal DisordersDenmark
-
Aalborg UniversityAarhus University Hospital; National Research Centre for the Working Environment... and other collaboratorsNot yet recruitingWork-Related Musculoskeletal DisordersDenmark
-
University Hospital, AngersUnknown